Sustainable development for the healthcare industry : reprogramming the healthcare value chain /: reprogramming the healthcare value chain. ([2014])
- Record Type:
- Book
- Title:
- Sustainable development for the healthcare industry : reprogramming the healthcare value chain /: reprogramming the healthcare value chain. ([2014])
- Main Title:
- Sustainable development for the healthcare industry : reprogramming the healthcare value chain
- Further Information:
- Note: Pierre A. Morgon, editor.
- Editors:
- Morgon, Pierre A
- Contents:
- About the Editor and Contributors; Chapter-1; Sustainable Development for the Health-Care Industry: Setting the Stage; Human Society Has Always Been Focused on Health; The Mission of the Health-Care Industry; The Life Cycle of Pharmaceutical Products; The Mega Trends Which Affect the Health-Care Industry; Societal Expectations for Personalized Medicine; The DNA of the Health-Care Industry: Evolving Management of Innovation; Sustainability and Pharmaceutical Products: Role in Human Health (Mistra Pharma 2009). Pharmaceutical Products and Contribution to Global Health: Global Health Requires More than Better DrugsSustainable Concerns All Along the Life Cycle of the Health-care Industry; R & D; Manufacturing and Supply Chain; Licensing and Market Access; Consumption of Health-Care Products: Use, Access, and Disease Management; Global Corporate Governance; Conclusion; References; Chapter-2; Can Innovation Still Be the Main Growth Driver of the Pharmaceutical Industry?; Innovation as a Driver of Growth for the Pharmaceutical Industry in the Past; The Pharmaceutical Industry Today. The R & D Investments of Top Pharmaceutical CompaniesThe Output of Pharmaceutical R & D; The Pharmaceutical Innovation Process; The Success Rates of Pharmaceutical R & D; The Timelines of Pharmaceutical R & D; The Cost of Pharmaceutical R & D; A Steady-State R & D Model; The Reduced R & D Efficiency; Consequences of the Reduced R & D Efficiency; Increasing the Number of Projects in the R & D Pipeline;About the Editor and Contributors; Chapter-1; Sustainable Development for the Health-Care Industry: Setting the Stage; Human Society Has Always Been Focused on Health; The Mission of the Health-Care Industry; The Life Cycle of Pharmaceutical Products; The Mega Trends Which Affect the Health-Care Industry; Societal Expectations for Personalized Medicine; The DNA of the Health-Care Industry: Evolving Management of Innovation; Sustainability and Pharmaceutical Products: Role in Human Health (Mistra Pharma 2009). Pharmaceutical Products and Contribution to Global Health: Global Health Requires More than Better DrugsSustainable Concerns All Along the Life Cycle of the Health-care Industry; R & D; Manufacturing and Supply Chain; Licensing and Market Access; Consumption of Health-Care Products: Use, Access, and Disease Management; Global Corporate Governance; Conclusion; References; Chapter-2; Can Innovation Still Be the Main Growth Driver of the Pharmaceutical Industry?; Innovation as a Driver of Growth for the Pharmaceutical Industry in the Past; The Pharmaceutical Industry Today. The R & D Investments of Top Pharmaceutical CompaniesThe Output of Pharmaceutical R & D; The Pharmaceutical Innovation Process; The Success Rates of Pharmaceutical R & D; The Timelines of Pharmaceutical R & D; The Cost of Pharmaceutical R & D; A Steady-State R & D Model; The Reduced R & D Efficiency; Consequences of the Reduced R & D Efficiency; Increasing the Number of Projects in the R & D Pipeline; Reducing Costs of R & D; Measuring Performance and Managing the Project Portfolio Actively; Opening R & D Towards External Innovation; Sustainable Growth in Times of Reduced R & D Efficiency. Increasing Pressure from Generic DrugsSustainability Must Come from R & D; References; The Importance of Understanding the 'Lived Experience' of Patients in Pharmaceutical Development Programmes; Chapter-3; Introduction; How Can We Make Sure We Look Beyond the Science and Capture the 'Human Being' in Our Data?; Is the Pharmaceutical Industry Brave Enough to Let Patients Contribute to Driving the Research Agenda?; So How Do We Facilitate This?; How Can We Benefit From This Sort of Research?; Building the Value Chain With Patients Playing a Key Role; So What Can We Do to Drive Change? Why Bother?Chapter-4; Listening to the Voice of the Patient to Facilitate Earlier Access to Promising Medicines: Interview with Sjaak Vink; Chapter-5; Drivers of the Real-World Data Revolution and the Transition to Adaptive Licensing: Interview with Dr. Richard Barker; CASMI (Center for the Advancement of Sustainable Medical Innovation); Chapter-6; Sustainable Development for the Healthcare Industry: Vantage Point from Emerging Economies; Introduction; Sustainable Commercialization; Roles Played by MNCs Versus Local Manufacturers in Emerging Economies; Vantage Point; Regulations. … (more)
- Publisher Details:
- Cham : Springer
- Publication Date:
- 2014
- Copyright Date:
- 2015
- Extent:
- 1 online resource (x, 154 pages), color illustrations
- Subjects:
- 338.4/73621
Business
Medical economics
Sustainable development
Health Care Sector -- economics
BUSINESS & ECONOMICS -- Industries -- General
Medical economics
Sustainable development
Business & Economics -- Production & Operations Management
Science -- Environmental Science
Management of specific areas
Research & development management
Sustainability
Management science
Health care management
Production management
Management
Medical -- Administration
Health economics
Electronic books - Languages:
- English
- ISBNs:
- 9783319125268
3319125265
3319125257
9783319125251 - Related ISBNs:
- 9783319125251
- Notes:
- Note: Online resource; title from PDF title page (SpringerLink, viewed December 31, 2014).
- Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.361186
- Ingest File:
- 01_325.xml